Lead the implementation of the MCL role as part of the new HEOR team in support of building out a dedicated HEOR team within medical affairs.Deliver up-to-date scientific information to population health decision makers such as regional and national payors, GPOs and IDNs while obtaining key insights valuable in planning the HEOR tactics in line with organizational strategy. Stay abreast of the latest scientific and medical developments in the MPN space as well as market access trends by attending associated conferences and congresses.Key Contributions:▪ Build and lead the review process for MCL capabilities such as MCL clinical decks, engagement plans, and conference/congress plans.▪ Establish best practices and ways of collaborating with market access colleagues.▪ Provide clinical expertise to ongoing HEOR, RWE and PRO research projects, abstracts, and publications.▪ Identify KOLs to partner with and consult on evidence generation research projects.▪ Provide medical contributions to the expanding market access of our lead compound and its positioning within nationally recognized therapeutic guidelines.▪ Represent medical affairs at patient advocacy meetings.▪ Provide education and training on medical and/or clinical content to market access colleagues.

Support the launch of a newly approved drug by building territory development plans and establishing meaningful relationships with key opinion leaders (KOLs) throughout the Northeast territory.Ensure the delivery of up-to-date scientific information while obtaining key insights from KOLs that may be valuable in strategizing the PharmaEssentia clinical program. Stay abreast of the latest scientific and medical developments in the MPN space by attending associated conferences and congresses.Key Contributions:▪ Provide medical support and expertise in cross-functional working groups such as marketing access and cross-functional strategic planning.▪ Identify thought leaders and engage and communicate with top thought leaders to obtain key scientific in-sights.▪ Identify key sites for clinical programs.▪ MSL Market Access Lead: Establish processes and facilitate market access by providing medical support and expertise: provider letters, support at key meetings, presentation to key stakeholders.▪ Facilitate HEOR capabilities: consult on health economic and real-world evidence studies, vendor management, review of protocols, SOPs, and identification of KOLs.▪ Support Quarterly Business Review (QBR) and maintain the Executive dashboard.▪ Represent medical affairs at patient advocacy meetings.

Design and execute business plans for the heme- oncology pod of the specialty pharmacy.Design options for pharmacy services with a customer service and fiscal focus. Launch the oncology pod services for the newly developed specialty pharmacy of Partners Healthcare. Develop and contribute presentations for providers and clinical support staff on new developed pharmacy services. Coach and educate clinic providers and support staff on processes. Achieve a 90% approval rate on appeals of prior authorization denials by researching NCCN guidelines and published literature to support the off-label use of oncology products.Developing the patient base by practicing patient centered care in the provision of medication therapy management. Implement process improvement plans to improve clinic and patient satisfaction. Develop, implement and maintain optimal relationships with clinic staff and patients to grow and develop specialty pharmacy services. Strongly influence the prescribing habits of providers by utilizing change management. Lead by behaving as a resource for solving problems and issues that occur.Supervise and train Patient Care Coordinators.

Negotiated editing recommendations to sponsors when reviewing study documents to ensure safety and feasibility of investigational drug studies. Supervised the implementation of studies to ensure they are conducted per clinical practice guidelines and in line with institutional SOPs and per the protocol. Managed and led the pharmacy activities of more than100 studies simultaneously for hematology/oncology from study start up to maintenance and close-out. Managed the clinical supply of up to 200 investigational drugs simultaneously, including forecasting, packaging, labeling, distribution, and monitoring inventory. Forecasted the clinical trial supply demand by reviewing and analyzing protocols for study design, rate of enrollment and dosing schedule. Expanded pharmacy services for investigator initiated studies to stream-line and short the IRB approval and study activation process. Directed the blinding of study drug and procurement of matching placebo for placebo controlled trials. Supervised the pharmacy staff during the randomization assignment of the research participant to ensure he/she receives the appropriate drug or placebo. Established pharmacy services for the implementation of CAR-T studies and live vaccine studies. Established pharmacy presence in interdisciplinary meetings. Improved processes between different departments, increasing efficiencies and safety of participants. Supervised and led successful sponsor and FDA pharmacy audits. Supervised and coached pharmacy technicians and pharmacy students. Increased incident reporting by 30 %. Lead the resolution of study set-backs, such as temperature excursions and errors with order sets. Subject Matter Expert in the validation of 100’s of medication builds and research order sets for the new electronic health record system (Epic) in time for the go live date of April 2nd, 2016.

Counseled patients on pharmacotherapy and disease states. Dispensed medications and screened orders for therapeutic appropriateness and for any potential drug interactions and/or disease state interactions. Assisted patients in minimizing drug costs. Assisted in developing an immunization and lab program in the pharmacy. Participated in Medication Therapy Management as an Outcomes and Mirixa provider.Administered pneumonia, influenza and shingles vaccines and screened patients for vaccinations based upon recommendation from the CDC. Performed lipid test utilizing the Cholestech LDX Lipid System, A1C testing on patients utilizing the Bayer A1C system, blood pressure monitoring, and blood glucose test utilizing various blood glucose systems